318 related articles for article (PubMed ID: 9642130)
21. Antiinflammatory roles of peroxisome proliferator-activated receptor gamma in human alveolar macrophages.
Asada K; Sasaki S; Suda T; Chida K; Nakamura H
Am J Respir Crit Care Med; 2004 Jan; 169(2):195-200. PubMed ID: 14563653
[TBL] [Abstract][Full Text] [Related]
22. Vascular inflammation is negatively autoregulated by interaction between CCAAT/enhancer-binding protein-delta and peroxisome proliferator-activated receptor-gamma.
Takata Y; Kitami Y; Yang ZH; Nakamura M; Okura T; Hiwada K
Circ Res; 2002 Sep; 91(5):427-33. PubMed ID: 12215492
[TBL] [Abstract][Full Text] [Related]
23. Troglitazone effects on gene expression in human skeletal muscle of type II diabetes involve up-regulation of peroxisome proliferator-activated receptor-gamma.
Park KS; Ciaraldi TP; Lindgren K; Abrams-Carter L; Mudaliar S; Nikoulina SE; Tufari SR; Veerkamp JH; Vidal-Puig A; Henry RR
J Clin Endocrinol Metab; 1998 Aug; 83(8):2830-5. PubMed ID: 9709955
[TBL] [Abstract][Full Text] [Related]
24. Characteristics of the peroxisome proliferator activated receptor gamma (PPARgamma) ligand induced apoptosis in colon cancer cells.
Shimada T; Kojima K; Yoshiura K; Hiraishi H; Terano A
Gut; 2002 May; 50(5):658-64. PubMed ID: 11950812
[TBL] [Abstract][Full Text] [Related]
25. Identification of a functional peroxisome proliferator-activated receptor response element in the rat catalase promoter.
Girnun GD; Domann FE; Moore SA; Robbins ME
Mol Endocrinol; 2002 Dec; 16(12):2793-801. PubMed ID: 12456800
[TBL] [Abstract][Full Text] [Related]
26. Peroxisome proliferator-activated receptor gamma transcriptional regulation is involved in platelet-derived growth factor-induced proliferation of human hepatic stellate cells.
Galli A; Crabb D; Price D; Ceni E; Salzano R; Surrenti C; Casini A
Hepatology; 2000 Jan; 31(1):101-8. PubMed ID: 10613734
[TBL] [Abstract][Full Text] [Related]
27. Peroxisome proliferator-activated receptor (PPAR)-gamma expression in human vascular smooth muscle cells: inhibition of growth, migration, and c-fos expression by the peroxisome proliferator-activated receptor (PPAR)-gamma activator troglitazone.
Benson S; Wu J; Padmanabhan S; Kurtz TW; Pershadsingh HA
Am J Hypertens; 2000 Jan; 13(1 Pt 1):74-82. PubMed ID: 10678274
[TBL] [Abstract][Full Text] [Related]
28. Peroxisome proliferator-activated receptor-gamma activity is associated with renal microvasculature.
Guan Y; Zhang Y; Schneider A; Davis L; Breyer RM; Breyer MD
Am J Physiol Renal Physiol; 2001 Dec; 281(6):F1036-46. PubMed ID: 11704554
[TBL] [Abstract][Full Text] [Related]
29. PPARalpha and PPARgamma activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene.
Schoonjans K; Peinado-Onsurbe J; Lefebvre AM; Heyman RA; Briggs M; Deeb S; Staels B; Auwerx J
EMBO J; 1996 Oct; 15(19):5336-48. PubMed ID: 8895578
[TBL] [Abstract][Full Text] [Related]
30. Ligands of peroxisome proliferator-activated receptor-gamma induce apoptosis in AR42J cells.
Masamune A; Satoh K; Sakai Y; Yoshida M; Satoh A; Shimosegawa T
Pancreas; 2002 Mar; 24(2):130-8. PubMed ID: 11854617
[TBL] [Abstract][Full Text] [Related]
31. Ligands for peroxisome proliferator-activated receptor gamma inhibit growth and induce apoptosis of human papillary thyroid carcinoma cells.
Ohta K; Endo T; Haraguchi K; Hershman JM; Onaya T
J Clin Endocrinol Metab; 2001 May; 86(5):2170-7. PubMed ID: 11344222
[TBL] [Abstract][Full Text] [Related]
32. Expression of peroxisome proliferator-activated receptor gamma in renal cell carcinoma and growth inhibition by its agonists.
Inoue K; Kawahito Y; Tsubouchi Y; Kohno M; Yoshimura R; Yoshikawa T; Sano H
Biochem Biophys Res Commun; 2001 Sep; 287(3):727-32. PubMed ID: 11563856
[TBL] [Abstract][Full Text] [Related]
33. Putative activation of the peroxisome proliferator-activated receptor gamma impairs androgen and enhances progesterone biosynthesis in primary cultures of porcine theca cells.
Schoppee PD; Garmey JC; Veldhuis JD
Biol Reprod; 2002 Jan; 66(1):190-8. PubMed ID: 11751282
[TBL] [Abstract][Full Text] [Related]
34. Peroxisome proliferator-activated receptor-gamma upregulates caveolin-1 and caveolin-2 expression in human carcinoma cells.
Burgermeister E; Tencer L; Liscovitch M
Oncogene; 2003 Jun; 22(25):3888-900. PubMed ID: 12813462
[TBL] [Abstract][Full Text] [Related]
35. DR1-like element in human topoisomerase IIalpha gene involved in enhancement of etoposide-induced apoptosis by PPARgamma ligand.
Kanbe E; Abe A; Towatari M; Kawabe T; Saito H; Emi N
Exp Hematol; 2003 Apr; 31(4):300-8. PubMed ID: 12691917
[TBL] [Abstract][Full Text] [Related]
36. PPARgamma activators down-regulate the expression of PPARgamma in 3T3-L1 adipocytes.
Camp HS; Whitton AL; Tafuri SR
FEBS Lett; 1999 Mar; 447(2-3):186-90. PubMed ID: 10214942
[TBL] [Abstract][Full Text] [Related]
37. Peroxisome proliferator-activated receptor gamma ligands, 15-deoxy-Delta12,14-prostaglandin J2, and ciglitazone, induce growth inhibition and cell cycle arrest in hepatic oval cells.
Cheng J; Nakamura H; Imanishi H; Liu W; Morisaki T; Sugiyama T; Hada T
Biochem Biophys Res Commun; 2004 Sep; 322(2):458-64. PubMed ID: 15325252
[TBL] [Abstract][Full Text] [Related]
38. Role of peroxisome proliferator-activated receptor gamma and its ligands in non-neoplastic and neoplastic human urothelial cells.
Nakashiro KI; Hayashi Y; Kita A; Tamatani T; Chlenski A; Usuda N; Hattori K; Reddy JK; Oyasu R
Am J Pathol; 2001 Aug; 159(2):591-7. PubMed ID: 11485917
[TBL] [Abstract][Full Text] [Related]
39. Peroxisome proliferator-activated receptor gamma ligands inhibit mitogenic induction of p21(Cip1) by modulating the protein kinase Cdelta pathway in vascular smooth muscle cells.
Wakino S; Kintscher U; Liu Z; Kim S; Yin F; Ohba M; Kuroki T; Schönthal AH; Hsueh WA; Law RE
J Biol Chem; 2001 Dec; 276(50):47650-7. PubMed ID: 11598137
[TBL] [Abstract][Full Text] [Related]
40. Peroxisome proliferator-activated receptor gamma activators downregulate angiotensin II type 1 receptor in vascular smooth muscle cells.
Takeda K; Ichiki T; Tokunou T; Funakoshi Y; Iino N; Hirano K; Kanaide H; Takeshita A
Circulation; 2000 Oct; 102(15):1834-9. PubMed ID: 11023940
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]